Narcobarbital
From Wikipedia, the free encyclopedia
|
Narcobarbital
|
|
| Systematic (IUPAC) name | |
| 5-(2-bromoprop-2-enyl)-1-methyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C11H15BrN2O3 |
| Mol. mass | 303.152 g/mol |
| Synonyms | Narcobarbital, Pronarcon |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Narcobarbital (Pronarcon) is a barbiturate derivative invented in the 1960s. It is an N-methylated derivative of Propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.
[edit] References
|
|||||

